Aspira Womans Health Stock Price

-0.03 (-0.61%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aspira Womans Health Inc AWH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -0.61% 4.88 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.85 4.68 4.94 4.88 4.91
Bid Price Ask Price Spread News
4.88 5.69 0.81 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
981 185,644 $ 4.88 $ 905,069 - 2.4656 - 10.54
Last Trade Time Type Quantity Stock Price Currency
16:01:32 10 $ 4.88 USD


Draw Mode:

Aspira Womans Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 546.30M 111.95M 84.88M $ 4.65M $ - -0.18 -26.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 9.00%

more financials information »

Aspira Womans Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AWH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.905.0554.614.85219,737-0.02-0.41%
1 Month5.935.964.595.33424,715-1.05-17.71%
3 Months5.766.394.595.45428,891-0.88-15.28%
6 Months5.9010.544.596.85653,226-1.02-17.29%
1 Year4.2210.542.46565.47658,0610.6615.64%
3 Years4.1410.542.46565.30692,8100.7417.87%
5 Years4.1410.542.46565.30692,8100.7417.87%

Aspira Womans Health Description

Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.

Your Recent History
Aspira Wom..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.